Singapore markets closed

RespireRx Pharmaceuticals Inc. (RSPI)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.0040+0.0003 (+8.11%)
At close: 03:46PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
313.245
429.532
702.043
638.275
599.329
Selling general and administrative
1,095
1,150
1,857
2,677
1,137
Total operating expenses
1,408
1,579
2,559
3,315
1,737
Operating income or loss
-1,408
-1,579
-2,559
-3,315
-1,737
Interest expense
435.735
603.818
724.769
545.675
404.661
Total other income/expenses net
47.297
80.453
139.057
-440.401
26.132
Income before tax
-1,796
-2,103
-3,145
-4,301
-2,115
Income from continuing operations
-1,796
-2,103
-3,145
-4,301
-2,115
Net income
-1,796
-2,103
-3,145
-4,301
-2,115
Net income available to common shareholders
-2,171
-3,973
-3,523
-5,741
-2,115
Basic EPS
-0.02
-0.04
-0.04
-0.02
-5.41
Diluted EPS
-0.02
-0.04
-0.04
-0.02
-5.41
Basic average shares
173,892
111,323
88,347
258,557
390.848
Diluted average shares
173,892
111,323
88,347
258,557
390.848